PharmAthene, a biodefence company, has appointed Charles Reinhart III to the position of senior vice president (SVP), chief financial officer (CFO), with responsibility for overseeing the company’s accounting and finance functions, human resources and information technology. Christopher Camut, who held the position of vice president and CFO since January 2007, has been appointed to the newly created position of vice president, government contracting and special projects.
Prior to joining PharmAthene, Reinhart served as SVP finance and corporate strategy, and was a member of the operating leadership team of Millennium Pharmaceuticals, where he was responsible for all aspects of the company’s finance and strategic sourcing functions.
Previously, Reinhart was vice president of finance at Cephalon, where he was responsible for worldwide accounting, financial reporting, Sarbanes Oxley (SOX) compliance, tax, treasury and budgeting/forecasting functions, and was a key member of the team responsible for raising over US$2.6bn in convertible debt transactions.
Reinhart is a certified public accountant (CPA). He earned his MBA from The Wharton School at the University of Pennsylvania and his undergraduate degree in Business and Economics from Lehigh University. He currently serves as a member of the board of directors of VectorLogics.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more